U.S. equities saw a rotation last week as major indices diverged. S&P 500 and Nasdaq fell 1.95% and 4.60% respectively, hit by a tech correction amid valuation fatigue. Conversely, the Dow and Russell 2000 rose, signaling a shift toward value. Healthcare (+7.88%) and real estate (+4.16%) led as defensive plays, while tech slid 5.32%. Inflation remained sticky, forcing a pivot from speculative growth to defensive resilience. Investors now prioritize profitability and margin protection amid rate uncertainty.
Market Review and Analysis
The macroeconomic landscape during the week of June 22 to June 28, 2026, was dominated by sticky inflation figures and shifting geopolitical dynamics. The Bureau of Economic Analysis released May PCE inflation data on June 25, showing headline PCE rose to 4.1 percent year-over-year, its highest level in three years, driven by energy price spikes from the conflict with Iran. Core PCE, excluding food and energy, rose 0.3 percent month-over-month and 3.4 percent year-over-year, highlighting persistent services inflation. Meanwhile, the final Q1 GDP estimate was revised upward to 2.1 percent, personal spending grew 0.7 percent in May, and weekly jobless claims dropped to 215,000, signaling labor market resilience. On a positive note, West Texas Intermediate crude dropped to $69.43 per barrel on progress toward peace talks, helping the 10-year Treasury yield ease to 4.38 percent.
In the equity markets, major averages exhibited a highly divided performance during the week of June 22 to June 26, 2026. The S&P 500 fell 1.95 percent to close at 7,354.02 and the tech-heavy Nasdaq Composite dropped 4.60 percent to 25,297.62, representing just the second losing week out of the past 13 as a sharp correction in semiconductor and artificial intelligence hardware stocks dragged down growth. Conversely, the Dow Jones Industrial Average rose 0.62 percent to 51,876.11, while the small-cap Russell 2000 index gained 1.0 percent to end at 3,010.08, indicating a robust rotation out of megacaps. Sector-wise, healthcare was the standout leader, surging 7.88 percent, followed by real estate, which advanced 4.16 percent, while technology fell 5.32 percent and consumer cyclicals slid 2.59 percent.
Key corporate and market events centered on valuation fatigue and rising supply-chain costs in the technology space. Although Micron Technology reported strong third-quarter earnings, the semiconductor sector fell into a correction as investors focused on soaring memory costs that prompted Apple and Microsoft to raise hardware prices. Further pressure mounted as ON Semiconductor plummeted 23.66 percent after agreeing to acquire Synaptics in a $7 billion all-stock deal. Sentiment was also weighed down by reports that OpenAI is considering delaying its public offering until 2027, causing selective reassessment of valuations. Conversely, Moderna surged nearly 13 percent after showcasing its pipeline, providing a strong lift to defensive sectors.
Fund flows and market sentiment reflected a clear de-risking of momentum positions and a rotation toward defensive value. The CBOE Volatility Index firmed slightly to 18.89, while some short-term metrics reached levels of extreme fear as the artificial intelligence trade paused. Market breadth remained remarkably healthy, with 61 percent of U.S.-listed stocks finishing the week higher despite index-level declines. This divergence underscores that rather than a broad, panic-driven retreat, institutional investors actively rotated capital out of overstretched technology megacaps and into lagging mid-cap, small-cap, and defensive dividend-paying equities.
The overall assessment indicates a transition phase where the market's logical foundation is shifting from speculative growth to defensive resilience. Sticky inflation has sidelined the Federal Reserve, raising concerns of a prolonged restrictive policy regime and making some price in potential rate hikes later in 2026. This macroeconomic stalemate, combined with rising input costs, is forcing a reassessment of multi-year capital expenditure pay-off periods for the artificial intelligence infrastructure trade. As a result, the market is exhibiting classic late-cycle characteristics, where equal-weight indexes outperform cap-weighted indices, and fundamental earnings delivery is prioritized over multiple expansion.
Next Week’s key market drivers and Investment Outlook
Looking ahead, the central focus next week will be the June Non-Farm Payrolls report, serving as a crucial indicator of labor market health and monetary policy direction. Additionally, investors will digest the ISM Manufacturing and Services PMI releases to evaluate economic activity and input-price pressures. Corporate earnings releases will slow, but updates on Middle East peace negotiations remain a major variable for energy prices. U.S. markets will be closed on Friday, July 3, in observance of the Independence Day holiday, resulting in a shortened trading week.
Macro conditions suggest the market will remain locked in a higher-for-longer rate framework, as the Federal Reserve requires more evidence of disinflation before cutting rates. If labor market data shows stabilization without a sharp rise in unemployment, economic growth should remain underpinned by solid capital spending and stable consumption. Micro-fundamentally, the logical driver for equities will focus on margin protection and cost-pass-through capability. As the second-quarter earnings season approaches, the market will reward companies that maintain profitability despite rising intermediate costs, while punishing those with valuations based purely on speculative growth narratives.
Strategy and allocation recommendations favor a balanced approach with a defensive bias. Strategists suggest maintaining solid exposure to defensive, dividend-paying sectors like healthcare, consumer staples, and utilities, which offer an attractive margin of safety. Within technology, investors should pivot toward software providers with strong pricing power and recurring revenues, while underweighting high-beta semiconductor and hardware makers exposed to rising costs. Furthermore, the robust momentum in small- and mid-cap spaces warrants a gradual increase in allocation, as equal-weight strategies are expected to outperform in this broader market setup.
Key risks deserve close attention, starting with a potential breakdown of Middle East peace negotiations, which could quickly reverse the decline in oil prices and reignite stagflationary pressures. Additionally, any upside surprises in wage growth or services inflation in upcoming economic releases would likely revive hawkish Fed expectations and trigger further valuation compression. Investors should also watch for capital expenditure reductions by technology hyperscalers, as any signs of cooling infrastructure spending would accelerate the tech correction. Finally, quarter-end liquidity fluctuations and thin order-book depth could exacerbate short-term price swings.
Sign up for Tradingkey to unlock the full content
Integrated Hardware & Software (+5.23%) rose on surging enterprise AI infrastructure demand. Specialty Retailers (+4.54%) climbed on resilient consumer spending and buyback programs. Professional & Business Education (+3.78%) gained from corporate upskilling and AI-driven platform adoption.
Last week, AbbVie (ABBV), Corning (GLW), and Merck (MRK) surged on strong, company-specific catalysts. AbbVie (+17.03%) gained momentum after announcing a $10.9 billion acquisition of Apogee Therapeutics to bolster its clinical immunology pipeline, alongside pediatric regulatory approvals for Skyrizi in the US and Europe. Corning (+13.41%) jumped following a key multibillion-dollar optical fiber supply agreement with Amazon to power AI data centers, prompting positive analyst price target upgrades. Merck (+12.99%) rallied on a Phase 3 trial success for its ulcerative colitis drug tulisokibart, positive FDA approvals for Keytruda combinations, and upwardly revised full-year 2026 financial guidance, driving robust investor demand.